histamine has been researched along with Sunburn in 6 studies
Sunburn: An injury to the skin causing erythema, tenderness, and sometimes blistering and resulting from excessive exposure to the sun. The reaction is produced by the ultraviolet radiation in sunlight.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Immediately after the injection of 100 µg histamine on both arms, subjects received topical treatment and pruritus was subsequently assessed with visual analogue scale (VASpruritus) and Eppendorfer questionnaire." | 9.20 | A double-blind, randomized clinical study to determine the efficacy of benzocaine 10% on histamine-induced pruritus and UVB-light induced slight sunburn pain. ( Bauer, M; Lang-Zwosta, I; Nishino, K; Scherzer, T; Schwameis, R; Zeitlinger, M, 2015) |
| " Immediately after the injection of 100 µg histamine on both arms, subjects received topical treatment and pruritus was subsequently assessed with visual analogue scale (VASpruritus) and Eppendorfer questionnaire." | 5.20 | A double-blind, randomized clinical study to determine the efficacy of benzocaine 10% on histamine-induced pruritus and UVB-light induced slight sunburn pain. ( Bauer, M; Lang-Zwosta, I; Nishino, K; Scherzer, T; Schwameis, R; Zeitlinger, M, 2015) |
| "The ultraviolet-induced erythema reaction was investigated histologically and biochemically in four subjects, utilizing suction blister aspirates, analyzed for histamine and prostaglandin E2 (PGE2), and Epon-embedded 1-mu skin biopsy sections from control skin and from irradiated skin at intervals for 72 hours after exposure to a Hanovia lamp." | 3.66 | The human sunburn reaction: histologic and biochemical studies. ( Gilchrest, BA; Mihm, MC; Soter, NA; Stoff, JS, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siiskonen, H | 1 |
| Smorodchenko, A | 1 |
| Krause, K | 1 |
| Maurer, M | 1 |
| Bauer, M | 1 |
| Schwameis, R | 1 |
| Scherzer, T | 1 |
| Lang-Zwosta, I | 1 |
| Nishino, K | 1 |
| Zeitlinger, M | 1 |
| Gilchrest, BA | 2 |
| Stoff, JS | 2 |
| Soter, NA | 2 |
| Mihm, MC | 1 |
| Tomita, Y | 1 |
| Maeda, K | 1 |
| Tagami, H | 1 |
| Greaves, MW | 1 |
| Sondergaard, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color[NCT01147172] | 100 participants (Actual) | Interventional | 2009-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Percentage of Subjects with keloid formation at the site of injection (NCT01147172)
Timeframe: 12 Weeks
| Intervention | Percentage (%) of subjects (Number) |
|---|---|
| Elevess | 0.0 |
Percentage of Subjects with keloid formation at the site of injection (NCT01147172)
Timeframe: 2 Weeks
| Intervention | percentage of participants (Number) |
|---|---|
| Elevess | 0.0 |
Percentage of Subjects with keloid formation at the site of injection (NCT01147172)
Timeframe: 6 Weeks
| Intervention | Percentage (%) of subjects (Number) |
|---|---|
| Elevess | 0.0 |
Percentage of subjects with keloid formation at the site of injection at End of Study (NCT01147172)
Timeframe: 24 Weeks
| Intervention | Percentage (%) of subjects (Number) |
|---|---|
| Elevess | 0.0 |
Percentage of Subjects with pigmentation changes at site of injection (NCT01147172)
Timeframe: 12 Weeks
| Intervention | Percentage (%) of subjects (Number) |
|---|---|
| Elevess | 2.0 |
Percentage of Subjects with pigmentation changes at site of injection (NCT01147172)
Timeframe: 2 Weeks
| Intervention | Percentage (%) of subjects (Number) |
|---|---|
| Elevess | 8.0 |
Percentage of Subjects with pigmentation changes at site of injection (NCT01147172)
Timeframe: 6 Weeks
| Intervention | Percentage (%) of subjects (Number) |
|---|---|
| Elevess | 3.0 |
Percentage of subjects with pigmentation changes at site of injection at End of Study (NCT01147172)
Timeframe: 24 Weeks
| Intervention | Percentage (%) of subjects (Number) |
|---|---|
| Elevess | 1.0 |
1 review available for histamine and Sunburn
| Article | Year |
|---|---|
Ultraviolet radiation and skin mast cells: Effects, mechanisms and relevance for skin diseases.
Topics: DNA Damage; Histamine; Humans; Inflammation; Lupus Erythematosus, Cutaneous; Mast Cells; Mastocytosi | 2018 |
1 trial available for histamine and Sunburn
| Article | Year |
|---|---|
A double-blind, randomized clinical study to determine the efficacy of benzocaine 10% on histamine-induced pruritus and UVB-light induced slight sunburn pain.
Topics: Administration, Topical; Adult; Benzocaine; Double-Blind Method; Histamine; Humans; Male; Ointments; | 2015 |
4 other studies available for histamine and Sunburn
| Article | Year |
|---|---|
Chronologic aging alters the response to ultraviolet-induced inflammation in human skin.
Topics: Adult; Aged; Aging; Dermatitis; Dinoprostone; Female; Histamine; Humans; Male; Prostaglandins E; Ski | 1982 |
The human sunburn reaction: histologic and biochemical studies.
Topics: Adult; Epidermis; Erythema; Female; Histamine; Humans; Male; Prostaglandins E; Skin; Sunburn; Ultrav | 1981 |
Mechanisms for hyperpigmentation in postinflammatory pigmentation, urticaria pigmentosa and sunburn.
Topics: Arachidonic Acids; Cells, Cultured; Cholecalciferol; Histamine; Humans; Inflammation; Melanins; Mela | 1989 |
Pharmacologic agents released in ultraviolet inflammation studied by continuous skin pefusion.
Topics: Histamine; Humans; Kinins; Muscle Contraction; Muscle, Smooth; Perfusion; Radiation Effects; Seroton | 1970 |